Gestational weight gain as a predictor of macrosomia and low birth weight: a systematic review

Gabriela Santos-Antonio1, Katherine Alvis-Chirinos1, Luis Aguilar-Esenarro1

  • 1Instituto Nacional de Salud, Lima, Perú.

Insights

Gestational weight gain recommendations from IOM and CLAP show limited predictive ability for low birth weight and neonatal macrosomia. Further research is needed for population-specific guidelines.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Gestational weight gain (GWG) is crucial for maternal and infant health.
  • Institute of Medicine (IOM) and Latin American Center of Perinatology (CLAP) provide GWG recommendations.
  • Predictive accuracy of these recommendations for adverse birth outcomes requires evaluation.

Purpose of the Study:

  • To assess the predictive capacity of IOM and CLAP GWG recommendations.
  • To determine their effectiveness in identifying risks for low birth weight (LBW) and neonatal macrosomia.

Main Methods:

  • Systematic literature search across multiple databases (PubMed, Embase, Cochrane, etc.).
  • Inclusion of 5 studies meeting specific criteria.
  • Methodological quality assessed using QUADAS-2 tool.

Main Results:

  • No studies evaluated CLAP recommendations; only 5 met inclusion criteria.
  • Predictive accuracy (sensitivity, specificity) for LBW and macrosomia varied significantly by country.
  • In Latin American cohorts, LBW prediction sensitivity was 62.8-74%, specificity 61.7-68%. Macrosomia prediction sensitivity was 28.8%, specificity 43.8%.
  • Positive predictive values were generally low (<25%), while negative predictive values were high (>90%).
  • Most included studies exhibited high risk of bias and applicability issues.

Conclusions:

  • Limited methodological quality and representativeness of studied cohorts were observed.
  • Modest predictive values and potential confounding factors highlight limitations.
  • Need for studies developing GWG recommendations tailored to specific epidemiological contexts, such as the Peruvian population.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
944
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
91
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
112